Advertisement

Squamous Cell Carcinoma

  • Jonathan G. Sham
  • Vlad V. Simianu
  • Zhao Ming Dong
  • Nicholas L. Compton
  • Peter C. Wu
Chapter

Abstract

Cutaneous squamous cell carcinoma (SCC) is a common cancer arising from malignant proliferation of epidermal keratinocytes. SCC represents a broad range of disease, from superficially invasive to aggressive, highly lethal tumors. This chapter will review the epidemiology, risk factors, pathogenesis, diagnosis, and treatment of cutaneous SCC, with a particular focus on disease in the lower extremity.

Keywords

Sentinel Lymph Node Basal Cell Carcinoma National Comprehensive Cancer Network Actinic Keratosis Cutaneous Squamous Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Pott P. Chirurgical observations relative to the cataract, the polyps of the nose, the cancer of the scrotum, the different kinds of ruptures, the mortification of the toes and feet. London: Hawes, Clarke and Collins; 1775.Google Scholar
  2. 2.
    Horton CE, Crawford HH, Love HG, Loeffler RA. The malignant potential of burn scar. Plast Reconstr Surg Transplant Bull. 1958;22(4):348–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Neubauer O. Arsenical cancer; a review. Br J Cancer. 1947;1(2):192–251.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Dabski K, Stoll Jr HL. Skin cancer caused by grenz rays. J Surg Oncol. 1986;31(2):87–93.PubMedCrossRefGoogle Scholar
  6. 6.
    Traenkle HL. X-ray-induced skin cancer in man. Natl Cancer Inst Monogr. 1963;10:423.Google Scholar
  7. 7.
    Gloster Jr HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Weinstock MA, Ultraviolet radiation and skin cancer: epidemiologic data from the United States and Canada. In: Young AR, Björn LO, Moan J, Nultsch W, editors. Environmental UV photobiology. New York: Plenum Press; 1993. p. 295.CrossRefGoogle Scholar
  9. 9.
    American Cancer Society. Cancer Facts and Figures. 2014. Atlanta:American Cancer Society. 2014.Google Scholar
  10. 10.
    Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Fleming ID, Barnawell JR, Burlison PE, Rankin JS. Skin cancer in black patients. Cancer. 1975;35(3):600–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Halder RM. Bang KM Skin cancer in blacks in the United States. Dermatol Clin. 1988;6(3):397–405.PubMedGoogle Scholar
  13. 13.
    Ishihara K, Saida T, Yamamoto A, Japanese Skin Cancer Society P, Statistical Investigation C. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol. 2001;6(3):109–16.PubMedCrossRefGoogle Scholar
  14. 14.
    Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968–97. Br J Dermatol. 2003;148(6):1161–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Amir H, Mbonde MP, Kitinya JN. Cutaneous squamous cell carcinoma in Tanzania. Cent Afr J Med. 1992;38(11):439–43.PubMedGoogle Scholar
  17. 17.
    Panda S. Nonmelanoma skin cancer in India: current scenario. Indian J Dermatol. 2010;55(4):373–8.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J Am Acad Dermatol. 1995;33(3):422–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni Jr JF. Recent cancer trends in the United States. J Natl Cancer Inst. 1995;87(3):175–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol. 1997;133(6):735–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Harris RB, Griffith K. Moon TE Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J Am Acad Dermatol. 2001;45(4):528–36.PubMedCrossRefGoogle Scholar
  22. 22.
    Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer (Journal international du cancer). 1993;53(4):585–90.CrossRefGoogle Scholar
  23. 23.
    Marks R. The epidemiology of non-melanoma skin cancer: who, why and what can we do about it. J Dermatol. 1995;22(11):853–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Hacker SM, Flowers FP. Squamous cell carcinoma of the skin. Will heightened awareness of risk factors slow its increase? Postgrad Med. 1993;93(8):115.PubMedCrossRefGoogle Scholar
  25. 25.
    Baldursson B, Sigurgeirsson B, Lindelof B. Leg ulcers and squamous cell carcinoma. An epidemiological study and a review of the literature. Acta Derm Venereol. 1993;73(3):171–4.PubMedGoogle Scholar
  26. 26.
    Kricker A, Armstrong BK. English DR Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994;5(4):367–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of the skin. A case–control study in the Montreal region. Cancer. 1985;55(4):907–11.PubMedCrossRefGoogle Scholar
  28. 28.
    Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, Roenigk RK. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294(6):681–90.PubMedCrossRefGoogle Scholar
  29. 29.
    Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer (Journal international du cancer). 1999;81(4):555–9.CrossRefGoogle Scholar
  30. 30.
    Gallagher RP, Ma B, McLean DI, Yang CP, Ho V, Carruthers JA, Warshawski LM. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol. 1990;23(3 Pt 1):413–21.PubMedCrossRefGoogle Scholar
  31. 31.
    Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63(1–3):8–18.PubMedCrossRefGoogle Scholar
  32. 32.
    Osterlind A, Hou-Jensen K, Moller Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978–1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer. 1988;58(3):385–91.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Kim C, Ko CJ, Leffell DJ. Cutaneous squamous cell carcinomas of the lower extremity: a distinct subset of squamous cell carcinomas. J Am Acad Dermatol. 2014;70(1):70–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Chakravorty RC, Dutta-Choudhuri R. Malignant neoplasms of the skin in Eastern India. Indian J Cancer. 1968;5(2):133–44.PubMedGoogle Scholar
  35. 35.
    Camain R, Tuyns AJ, Sarrat H, Quenum C, Faye I. Cutaneous cancer in Dakar. J Natl Cancer Inst. 1972;48(1):33–49.PubMedGoogle Scholar
  36. 36.
    Tada M, Miki Y. Malignant skin tumors among dermatology patients in university hospitals of Japan. A statistical survey 1971–1975. J Dermatol. 1984;11(4):313–21.PubMedCrossRefGoogle Scholar
  37. 37.
    Yakubu A, Mabogunje OA. Squamous cell carcinoma of the skin in Africans. Trop Geogr Med. 1995;47(2):91–3.PubMedGoogle Scholar
  38. 38.
    Goldsmith LA, Fitzpatrick TB. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill Professional; 2012.Google Scholar
  39. 39.
    Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75(2 Suppl):667–73.PubMedCrossRefGoogle Scholar
  40. 40.
    Montagna W, Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol. 1991;24(6 Pt 1):929–37.PubMedCrossRefGoogle Scholar
  41. 41.
    Kollias N, Sayre RM, Zeise L. Chedekel MR Photoprotection by melanin. J Photochem Photobiol B. 1991;9(2):135–60.PubMedCrossRefGoogle Scholar
  42. 42.
    Vitaliano PP, Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol. 1980;116(4):454–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Levi F, La Vecchia C, Te VC, Mezzanotte G. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer (Journal international du cancer). 1988;42(6):811–6.CrossRefGoogle Scholar
  44. 44.
    Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354(9180):723–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Cockayne SE, August PJ. PUVA photocarcinogenesis in Cheshire. Clin Exp Dermatol. 1997;22(6):300–1.PubMedCrossRefGoogle Scholar
  46. 46.
    Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol. 2003;121(2):252–8.PubMedCrossRefGoogle Scholar
  47. 47.
    English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case–control study. Int J Cancer (Journal international du cancer). 1998;76(5):628–34.CrossRefGoogle Scholar
  48. 48.
    Stern RS, Study PF-U. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553–62.PubMedCrossRefGoogle Scholar
  49. 49.
    Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst. 2002;94(3):224–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Lever LR, Lawrence CM. Nonmelanoma skin cancer associated with use of a tanning bed. N Engl J Med. 1995;332(21):1450–1.PubMedCrossRefGoogle Scholar
  51. 51.
    Roest MA, Keane FM, Agnew K, Hawk JL, Griffiths WA. Multiple squamous skin carcinomas following excess sunbed use. J R Soc Med. 2001;94(12):636–7.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Wehner MR, Shive ML, Chren MM, Han J, Qureshi AA, Linos E. Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ (Clinical research ed). 2012;345:e5909.Google Scholar
  53. 53.
    Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol. 2000;136(8):1007–11.PubMedCrossRefGoogle Scholar
  54. 54.
    Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990;49(3):506–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P. Simonsen S Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2 Pt 1):177–86.PubMedCrossRefGoogle Scholar
  56. 56.
    Lampros TD, Cobanoglu A, Parker F, Ratkovec R, Norman DJ, Hershberger R. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant. 1998;17(6):586–91.PubMedGoogle Scholar
  57. 57.
    Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1–17.PubMedCrossRefGoogle Scholar
  58. 58.
    Silverberg MJ, Leyden W, Warton EM, Quesenberry Jr CP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013;105(5):350–60.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26(3 Pt 2):467–84.PubMedCrossRefGoogle Scholar
  60. 60.
    Veness MJ. Aggressive skin cancers in a cardiac transplant recipient. Australas Radiol. 1997;41(4):363–6.PubMedCrossRefGoogle Scholar
  61. 61.
    Parrish JA. Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med. 2005;353(25):2712–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Brewer JD, Colegio OR, Phillips PK, Roenigk RK, Jacobs MA, Van de Beek D, Dierkhising RA, Kremers WK, McGregor CG, Otley CC. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol. 2009;145(12):1391–6.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Phillips TJ, Salman SM, Bhawan J, Rogers GS. Burn scar carcinoma. Diagnosis and management. Dermatol Surg. 1998;24(5):561–5.PubMedCrossRefGoogle Scholar
  64. 64.
    Jellouli-Elloumi A, Kochbati L, Dhraief S, Ben Romdhane K, Maalej M. Cancers arising from burn scars: 62 cases. Ann Dermatol Venereol. 2003;130(4):413–6.PubMedGoogle Scholar
  65. 65.
    Love RL, Breidahl AF. Acute squamous cell carcinoma arising within a recent burn scar in a 14-year-old boy. Plast Reconstr Surg. 2000;106(5):1069–71.PubMedCrossRefGoogle Scholar
  66. 66.
    Akguner M, Marutcu A, Yilmaz M, Karatas O, Vayvada H. Marjolin’s ulcer and chronic burn scarring. J Wound Care. 1998;7(3):121–2.CrossRefGoogle Scholar
  67. 67.
    Friedman R, Hanson S, Goldberg LH. Squamous cell carcinoma arising in a Leishmania scar. Dermatol Surg. 2003;29(11):1148–9.PubMedGoogle Scholar
  68. 68.
    Gul U, Kilic A. Squamous cell carcinoma developing on burn scar. Ann Plast Surg. 2006;56(4):406–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis. Burns. 2005;31(4):403–13.PubMedCrossRefGoogle Scholar
  70. 70.
    Hussain SK, Sundquist J, Hemminki K. The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden. J Invest Dermatol. 2009;129(9):2142–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Milan T, Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Malignant skin cancers in the Finnish Twin Cohort: a population-based study, 1976–97. Br J Dermatol. 2002;147(3):509–12.PubMedCrossRefGoogle Scholar
  72. 72.
    Kharazmi E, Fallah M, Sundquist K, Hemminki K. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ (Clinical research ed). 2012;345:e8076.Google Scholar
  73. 73.
    Wallberg P, Kaaman T, Lindberg M. Multiple basal cell carcinoma. A clinical evaluation of risk factors. Acta Derm Venereol. 1998;78(2):127–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Hogan DJ, Lane PR, Gran L, Wong D. Risk factors for squamous cell carcinoma of the skin in Saskatchewan, Canada. J Dermatol Sci. 1990;1(2):97–101.PubMedCrossRefGoogle Scholar
  75. 75.
    Robinson JK, Altman JS, Rademaker AW. Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls. Arch Dermatol. 1995;131(4):428–31.PubMedCrossRefGoogle Scholar
  76. 76.
    Everall JD, Dowd PM. Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. Bull Cancer. 1978;65(3):241–7.PubMedGoogle Scholar
  77. 77.
    Guo HR, Yu HS, Hu H, Monson RR. Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control. 2001;12(10):909–16.PubMedCrossRefGoogle Scholar
  78. 78.
    Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case–control study. Am J Epidemiol. 2001;153(6):559–65.PubMedCrossRefGoogle Scholar
  79. 79.
    Leonardi-Bee J, Ellison T, Bath-Hextall F. Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol. 2012;148(8):939–46.PubMedCrossRefGoogle Scholar
  80. 80.
    Balmain A. Cancer genetics: from Boveri and Mendel to microarrays. Nat Rev Cancer. 2001;1(1):77–82.PubMedCrossRefGoogle Scholar
  81. 81.
    Lee JW, Soung YH, Kim SY, Nam HK, Park WS, Nam SW, Kim MS, Sun DI, Lee YS, Jang JJ, Lee JY, Yoo NJ, Lee SH. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005;11(8):2879–82.PubMedCrossRefGoogle Scholar
  82. 82.
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Baldursson BT, Beitner H, Syrjanen S. Human papillomavirus in venous ulcers with and without squamous cell carcinoma. Arch Dermatol Res. 2000;292(6):275–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Iwasaka T, Hayashi Y, Yokoyama M, Hara K, Matsuo N, Sugimori H. ‘Hit and run’ oncogenesis by human papillomavirus type 18 DNA. Acta Obstet Gynecol Scand. 1992;71(3):219–23.PubMedCrossRefGoogle Scholar
  85. 85.
    Brash DE. Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol. 2006;154 Suppl 1:8–10.PubMedCrossRefGoogle Scholar
  86. 86.
    Sakatani S, Kusakabe H, Kiyokane K, Suzuki K. p53 gene mutations in squamous cell carcinoma occurring in scars: comparison with p53 protein immunoreactivity. Am J Dermatopathol. 1998;20(5):463–7.PubMedCrossRefGoogle Scholar
  87. 87.
    Baldursson B, Syrjanen S, Beitner H. Expression of p21WAF1/CIP1, p53, bcl-2 and Ki-67 in venous leg ulcers with and without squamous cell carcinoma. Acta Derm Venereol. 2000;80(4):251–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Kennaway EL. On the cancer-producing factor in Tar. Br Med J. 1924;1(3300):564–7.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991;88(22):10124–8.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B. 2001;63(1–3):19–27.PubMedCrossRefGoogle Scholar
  91. 91.
    Ulrich M, Ruter C, Astner S, Sterry W, Lange-Asschenfeldt B, Stockfleth E, Rowert-Huber J. Comparison of UV-induced skin changes in sun-exposed vs. sun-protected skin- preliminary evaluation by reflectance confocal microscopy. Br J Dermatol. 2009;161 Suppl 3:46–53.PubMedCrossRefGoogle Scholar
  92. 92.
    Yantsos VA, Conrad N, Zabawski E, Cockerell CJ. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg. 1999;18(1):3–14.PubMedCrossRefGoogle Scholar
  93. 93.
    Heaphy Jr MR, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol. 2000;43(1 Pt 1):138–50.PubMedCrossRefGoogle Scholar
  94. 94.
    Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (“actinic keratosis”). J Am Acad Dermatol. 2000;42(1 Pt 2):11–7.PubMedCrossRefGoogle Scholar
  95. 95.
    Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1(8589):795–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol. 1991;127(7):1029–31.PubMedCrossRefGoogle Scholar
  97. 97.
    Carag HR, Prieto VG, Yballe LS, Shea CR. Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol. 2000;136(4):471–5.PubMedCrossRefGoogle Scholar
  98. 98.
    Bowen JT. Pre-Cancerous Dermatoses — a Study of 2 Cases of Chronic Atypical Epithelial Proliferation. J Cutan Dis. 1912;20:241.Google Scholar
  99. 99.
    Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER. Bowen’s disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J Am Acad Dermatol. 1994;31(4):596–600.PubMedCrossRefGoogle Scholar
  100. 100.
    Kao GF. Carcinoma arising in Bowen’s disease. Arch Dermatol. 1986;122(10):1124–6.PubMedCrossRefGoogle Scholar
  101. 101.
    Evans RD, Kopf AW, Lew RA, Rigel DS, Bart RS, Friedman RJ, Rivers JK. Risk factors for the development of malignant melanoma—I: Review of case–control studies. J Dermatol Surg Oncol. 1988;14(4):393–408.PubMedCrossRefGoogle Scholar
  102. 102.
    Zanetti R, Rosso S, Martinez C, Navarro C, Schraub S, Sancho-Garnier H, Franceschi S, Gafa L, Perea E, Tormo MJ, Laurent R, Schrameck C, Cristofolini M, Tumino R, Wechsler J. The multicentre south European study ‘Helios’. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73(11):1440–6.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM. Risk of c. utaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case–control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer (Journal international du cancer). 1995;62(4):367–76.CrossRefGoogle Scholar
  104. 104.
    Fitzpatrick TB. Ultraviolet-induced pigmentary changes: benefits and hazards. Curr Probl Dermatol. 1986;15:25–38.PubMedCrossRefGoogle Scholar
  105. 105.
    Vitasa BC, Taylor HR, Strickland PT, Rosenthal FS, West S, Abbey H, Ng SK, Munoz B, Emmett EA. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990;65(12):2811–7.PubMedCrossRefGoogle Scholar
  106. 106.
    Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, Threlfall WJ. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol. 1995;131(2):164–9.PubMedCrossRefGoogle Scholar
  107. 107.
    Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol. 1996;35(2 Pt 1):223–42.PubMedCrossRefGoogle Scholar
  108. 108.
    Reule RB, Golda NJ, Wheeland RG. Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature. Dermatol Surg. 2009;35(10):1559–66.PubMedCrossRefGoogle Scholar
  109. 109.
    Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, Sharfman WH, Shah JP, Nghiem P, Otley CC, Tufaro AP, Johnson TM, Sober AJ, Liegeois NJ. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol. 2011;64(6):1051–9.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Buethe D, Warner C, Miedler J, Cockerell CJ. Focus issue on squamous cell carcinoma: practical concerns regarding the 7th edition AJCC staging guidelines. J Skin Cancer. 2011;2011:156391.PubMedCrossRefGoogle Scholar
  111. 111.
    Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.PubMedCrossRefGoogle Scholar
  112. 112.
    North Jr JH, Spellman JE, Driscoll D, Velez A, Kraybill WG, Petrelli NJ. Advanced cutaneous squamous cell carcinoma of the trunk and extremity: analysis of prognostic factors. J Surg Oncol. 1997;64(3):212–7.PubMedCrossRefGoogle Scholar
  113. 113.
    Veness MJ. Time to rethink TNM staging in cutaneous SCC. Lancet Oncol. 2008;9(8):702–3.PubMedCrossRefGoogle Scholar
  114. 114.
    Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass LF, Grekin RC, Kessinger A, Lee NY, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Perlis CS, Rosenberg EW, Shaha AR, Urist MM, Wang LC, Zic JA. Basal cell and squamous cell skin cancers. J Natl Compr Cancer Netw. 2010;8(8):836–64.CrossRefGoogle Scholar
  115. 115.
    Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, Breuninger H. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713–20.PubMedCrossRefGoogle Scholar
  116. 116.
    Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, Ross MI, Cormier JN. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006;13(7):902–9.PubMedCrossRefGoogle Scholar
  117. 117.
    Mullen DL, Silverberg SG, Penn I, Hammond WS. Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer. 1976;37(2):729–34.PubMedCrossRefGoogle Scholar
  118. 118.
    Edwards MJ, Hirsch RM, Broadwater JR, Netscher DT, Ames FC. Squamous cell carcinoma arising in previously burned or irradiated skin. Arch Surg. 1989;124(1):115–7.PubMedCrossRefGoogle Scholar
  119. 119.
    Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol. 2011;9:80. doi: 10.1186/1477-7819-9-80.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    van Akkooi AC, Verhoef C. Eggermont AM Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol. 2010;7(8):446–54.PubMedCrossRefGoogle Scholar
  121. 121.
    Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, Graham GF, Lewis CW, Salasche SJ, Turner ML, et al. Guidelines of care for actinic keratoses. Committee on Guidelines of Care. J Am Acad Dermatol. 1995;32(1):95–8.PubMedCrossRefGoogle Scholar
  122. 122.
    Boddie Jr AW, Fischer EP, Byers RM. Squamous carcinoma of the lower lip in patients under 40 years of age. South Med J. 1977;70(6):711–2.PubMedCrossRefGoogle Scholar
  123. 123.
    Callen JP, Bickers DR, Moy RL. Actinic keratoses. J Am Acad Dermatol. 1997;36(4):650–3.PubMedCrossRefGoogle Scholar
  124. 124.
    Feldman SR, Fleischer Jr AB, Williford PM, Jorizzo JL. Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol. 1999;40(1):43–7.PubMedCrossRefGoogle Scholar
  125. 125.
    Lipper GM, Arndt KA, Dover JS. Recent therapeutic advances in dermatology. JAMA. 2000;283(2):175–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51(4):547–55.PubMedCrossRefGoogle Scholar
  127. 127.
    Lee PK, Harwell WB, Loven KH, Phillips TJ, Whiting DA, Andres KL, Lee JH. Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. Dermatol Surg. 2005;31(6):659–64.PubMedCrossRefGoogle Scholar
  128. 128.
    An KP, Athar M, Tang X, Katiyar SK, Russo J, Beech J, Aszterbaum M, Kopelovich L, Epstein Jr EH, Mukhtar H, Bickers DR. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol. 2002;76(1):73–80.PubMedCrossRefGoogle Scholar
  129. 129.
    Mohs F. Chemosurgery: a microscopially controlled method of skin cancer excision. Arch Surg. 1941;42(279):279.CrossRefGoogle Scholar
  130. 130.
    Tromovitch TA, Stegman SJ. Microscopie-controlled excision of cutaneous tumors: chemosurgery, fresh tissue technique. Cancer. 1978;41(2):653–8.PubMedCrossRefGoogle Scholar
  131. 131.
    Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Salasche SJ, Skouge JW, Turner ML, et al. Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol. 1995;33(2 Pt 1):271–8.PubMedGoogle Scholar
  132. 132.
    Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27(2 Pt 1):241–8.PubMedCrossRefGoogle Scholar
  133. 133.
    NCCN Clinical Practice Guidelines in Oncology. Basal and Squamous Cell Skin Cancers (V 2. 2014). http://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf. Accessed Apr 22 2014.
  134. 134.
    Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):748–55.PubMedCrossRefGoogle Scholar
  135. 135.
    Shimm DS, Wilder RB. Radiation therapy for squamous cell carcinoma of the skin. Am J Clin Oncol. 1991;14(5):383–6.PubMedCrossRefGoogle Scholar
  136. 136.
    Hashi N, Shirato H, Omatsu T, Kagei K, Nishioka T, Hashimoto S, Aoyama H, Fukuda S, Inuyama Y, Miyasaka K. The role of radiotherapy in treating squamous cell carcinoma of the external auditory canal, especially in early stages of disease. Radiother Oncol. 2000;56(2):221–5.PubMedCrossRefGoogle Scholar
  137. 137.
    Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman SM. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol. 2002;20(2):364–70.PubMedCrossRefGoogle Scholar
  138. 138.
    Suen JK, Bressler L, Shord SS, Warso M, Villano JL. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anticancer Drugs. 2007;18(7):827–9.PubMedCrossRefGoogle Scholar
  139. 139.
    Miller K, Sherman W, Ratner D. Complete clinical response to cetuximab in a patient with metastatic cutaneous squamous cell carcinoma. Dermatol Surg. 2010;36(12):2069–74.PubMedCrossRefGoogle Scholar
  140. 140.
    Maubec E, Petrow P, Scheer-Senyarich I, Duvillard P, Lacroix L, Gelly J, Certain A, Duval X, Crickx B, Buffard V, Basset-Seguin N, Saez P, Duval-Modeste AB, Adamski H, Mansard S, Grange F, Dompmartin A, Faivre S, Mentre F, Avril MF. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol. 2011;29(25):3419–26.PubMedCrossRefGoogle Scholar
  141. 141.
    Kim S, Eleff M, Nicolaou N. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck. 2011;33(2):286–8.PubMedCrossRefGoogle Scholar
  142. 142.
    Bauman JE, Eaton KD, Martins RG. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol. 2007;143(7):889–92.PubMedCrossRefGoogle Scholar
  143. 143.
    Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology. 2009;219(1):80–3.PubMedCrossRefGoogle Scholar
  144. 144.
    Perez CA, Song H, Raez LE, Agulnik M, Grushko TA, Dekker A, Stenson K, Blair EA, Olopade OI, Seiwert TY, Vokes EE, Cohen EE. Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2012;48(9):887–92.PubMedCrossRefGoogle Scholar
  145. 145.
    Robinson J. Follow-up and prevention (Basal Cell Carcinoma). In: Miller S, Maloney M, editors. Cutaneous Oncology Pathophysiology, diagnosis and management. Malden, MA: Blackwell Science; 1998.Google Scholar
  146. 146.
    Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136(12):1524–30.PubMedCrossRefGoogle Scholar
  147. 147.
    Shin D, Maloney M, Lippman S. Follow-up and prevention (Squamous Cell Carcinoma). In: Miller S, Maloney M, editors. Cutaneous Oncology Pathophysiology, diagnosis, and management. Malden, MA: Blackwell Science; 1998.Google Scholar
  148. 148.
    Arons MS, Lynch JB, Lewis SR, Blocker Jr TG. Scar Tissue carcinoma. A clinical study with special reference to burn scar carcinoma. Ann Surg. 1965;161:170–88.PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Fitzpatrick T, Eisen A, Wolff K, Stoll H, Schwartz R. Squamous cell carcinoma. In: Dermatology in General Medicine. New York: McGraw Hill; 1987. p. 746–58.Google Scholar
  150. 150.
    Martin H, Strong E, Spiro RH. Radiation induced skin cancer of the head and neck. Cancer. 1970;25(1):61–71.PubMedCrossRefGoogle Scholar
  151. 151.
    Cherpelis BS, Marcusen C, Land PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28(3):268–73.PubMedGoogle Scholar
  152. 152.
    Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998;124(5):582–7.PubMedCrossRefGoogle Scholar
  153. 153.
    Clayman GL, Lee JJ, Hoisinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23(4):759–65.PubMedCrossRefGoogle Scholar
  154. 154.
    Goepfeft H, dichtel JJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):5420547.Google Scholar
  155. 155.
    Garcia-Serra A, Hinerman RW, Mendenhall WM, amdur RJ, Morris CG, Williams LS, Mancuso AA. Carcinoma of the skin with perineural invasion. Head Neck. 2003;25(12):1027–33.PubMedCrossRefGoogle Scholar
  156. 156.
    Weimar VM, Ceilley RI, Goeken JA. Aggressive biologic behavior of basal and squamous cell cancers in patients with chronic lymphocytic leukemia or chronic lymphoma. J Dermatol Surg Oncol. 1979;5(8):609–14.PubMedCrossRefGoogle Scholar
  157. 157.
    Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2005;53(6):1067–71.PubMedCrossRefGoogle Scholar
  158. 158.
    Frierson Jr HF, Deutsch BD, Levine PA. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol. 1988;19(12):1397–402.PubMedCrossRefGoogle Scholar
  159. 159.
    Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc. 1993;25(1 PT 2):1383–4.PubMedGoogle Scholar
  160. 160.
    Euvrard S, Kanitakis J, Pouteil-Noble C, Disant F, Dureau G, Finazdevillaine J, Claudy A, Thivolet J. Aggressive squamous cell carcinomas in organ transplant recipients. Transplanat Proc. 1995;27(2):1767–8.Google Scholar
  161. 161.
    Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systemic review of the English literature. Dermatol Surg. 2006;32:1309. doi: 10.1111/j.1524-4725.2006.32300.x.PubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Jonathan G. Sham
    • 1
  • Vlad V. Simianu
    • 1
  • Zhao Ming Dong
    • 2
  • Nicholas L. Compton
    • 3
  • Peter C. Wu
    • 4
  1. 1.Department of SurgeryUniversity of Washington SeattleSeattleUSA
  2. 2.Department of PathologyUniversity of Washington/VA Puget SoundSeattleUSA
  3. 3.Division of Dermatology, Department of MedicineUniversity of Washington/VA Puget SoundSeattleUSA
  4. 4.Section of Surgical Oncology, Department of SurgeryUniversity of Washington/VA Puget SoundSeattleUSA

Personalised recommendations